Alaunos Therapeutics | ZIOP - Ordinary Share Capital


Alaunos Therapeutics reported $2.38M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Amgen USD 541M 1000K Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Baxter International USD 517M 549K Jun/2026
Biogen USD 146.7M 200K Sep/2025
Bioline Rx USD 2.61B 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celltrion KRW 229.65M 11.03M Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Curis USD 2M 10.93M Mar/2026
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Intrexon USD 0 0 Jun/2024
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Merck USD 2.47B 4.93M Mar/2026
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Novartis USD 1.9B 7.38M Jun/2026
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Pfizer USD 5.7B 0 Jun/2026
Pharma Mar EUR 17.34M 24.24K Jun/2026
PTC Therapeutics USD 82.88M 1.41M Mar/2026
Qiagen NV USD 206.5M 245K Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sartorius EUR 69.05M 0 Jun/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
TG Therapeutics USD 153.08M 2.23M Jun/2026
Tilray USD 116.52M 5.01M Sep/2025
Verastem USD 87.84M 10.1M Mar/2026
Zealand Pharma A/S 70.66M 53K Mar/2026
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026